BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16736146)

  • 1. Surgical treatment of giant cell tumour of long bone with anhydrous alcohol adjuvant.
    Oh JH; Yoon PW; Lee SH; Cho HS; Kim WS; Kim HS
    Int Orthop; 2006 Dec; 30(6):490-4. PubMed ID: 16736146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy.
    Trieb K; Bitzan P; Lang S; Dominkus M; Kotz R
    Eur J Surg Oncol; 2001 Mar; 27(2):200-2. PubMed ID: 11289759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone.
    Dürr HR; Maier M; Jansson V; Baur A; Refior HJ
    Eur J Surg Oncol; 1999 Dec; 25(6):610-8. PubMed ID: 10556009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case analysis on treatment and recurrence of giant cell tumor of bone].
    Zhang Z; Zhu B; Sun T
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1007-10. PubMed ID: 17140075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
    Gouin F; Dumaine V;
    Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?
    Gaston CL; Bhumbra R; Watanuki M; Abudu AT; Carter SR; Jeys LM; Tillman RM; Grimer RJ
    J Bone Joint Surg Br; 2011 Dec; 93(12):1665-9. PubMed ID: 22161931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
    Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
    Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant cell tumour of bone in the appendicular skeleton: an analysis of 276 cases.
    Xing R; Yang J; Kong Q; Tu C; Zhou Y; Duan H
    Acta Orthop Belg; 2013 Dec; 79(6):731-7. PubMed ID: 24563982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol as a local adjuvant for giant cell tumor of bone.
    Jones KB; DeYoung BR; Morcuende JA; Buckwalter JA
    Iowa Orthop J; 2006; 26():69-76. PubMed ID: 16789453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argon beam coagulation as an adjuvant for local control of giant cell tumor.
    Lewis VO; Wei A; Mendoza T; Primus F; Peabody T; Simon MA
    Clin Orthop Relat Res; 2007 Jan; 454():192-7. PubMed ID: 16957652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures.
    Chanchairujira K; Jiranantanakorn T; Phimolsarnti R; Asavamongkolkul A; Waikakul S
    J Med Assoc Thai; 2011 Oct; 94(10):1230-7. PubMed ID: 22145509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone.
    Gouin F; Rochwerger AR; Di Marco A; Rosset P; Bonnevialle P; Fiorenza F; Anract P
    Eur J Cancer; 2014 Sep; 50(14):2425-31. PubMed ID: 25088085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The analysis of the treatment of giant cell tumor of the pelvis and sacrum].
    Guo W; Tang XD; Li X; Ji T; Sun X
    Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(7):501-5. PubMed ID: 18785558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional results after giant cell tumor operation near knee joint and the cement radiolucent zone as indicator of recurrence.
    Kafchitsas K; Habermann B; Proschek D; Kurth A; Eberhardt C
    Anticancer Res; 2010 Sep; 30(9):3795-9. PubMed ID: 20944172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic effect of drugs eluted from polymethylmethacrylate on stromal giant-cell tumour cells: an in vitro study.
    Savadkoohi DG; Sadeghipour P; Attarian H; Sardari S; Eslamifar A; Shokrgozar MA
    J Bone Joint Surg Br; 2008 Jul; 90(7):973-9. PubMed ID: 18591612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of 51 intralesionally treated cases with progressed giant cell tumor of the bone: local adjuvant use of hydrogen peroxide reduces the risk for tumor recurrence.
    Omlor GW; Lange J; Streit M; Gantz S; Merle C; Germann T; Mechtersheimer G; Fellenberg J; Lehner B
    World J Surg Oncol; 2019 Apr; 17(1):73. PubMed ID: 31014317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-operation results in osteoarthritic change of knee joints in patients with giant cell tumor of bone.
    Suzuki Y; Nishida Y; Yamada Y; Tsukushi S; Sugiura H; Nakashima H; Ishiguro N
    Knee; 2007 Oct; 14(5):369-74. PubMed ID: 17601737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Curettage of giant cell tumors with temporary implantation of bone cement].
    Härle A; Wuisman P
    Z Orthop Ihre Grenzgeb; 1989; 127(4):382-6. PubMed ID: 2815936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the degenerative changes in weight-bearing joints following cementing or grafting techniques in giant cell tumour patients: medium-term results.
    Szalay K; Antal I; Kiss J; Szendroi M
    Int Orthop; 2006 Dec; 30(6):505-9. PubMed ID: 16969579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for recurrence of giant cell tumours of bone.
    Siddiqui MA; Seng C; Tan MH
    J Orthop Surg (Hong Kong); 2014 Apr; 22(1):108-10. PubMed ID: 24781627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.